Involvement of the presynaptic dopamine D2 receptor in the depression of spinal reflex by apomorphine

NeuroReport

Volumn 7, Issue 2, 1996, Pages 513-516

  Gajendiran, Mahadevan ^a   Seth, Pallab ^a   Ganguly, Dilip K ^a  

^a INDIAN INSTITUTE OF CHEMICAL BIOLOGY   (India)

Author keywords

apomorphine; dopamine receptors; presynaptic; rat; SCH 23390; SKF 38393; spinal cord; spinal reflex; spiperone

Indexed keywords

2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; APOMORPHINE; DOPAMINE 2 RECEPTOR; DOPAMINE RECEPTOR BLOCKING AGENT; DOPAMINE RECEPTOR STIMULATING AGENT; PRESYNAPTIC RECEPTOR; SPIPERONE;

ANIMAL EXPERIMENT; ARTICLE; BEHAVIOR; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SPINAL REFLEX;

EID: 0029912256     PISSN: 09594965     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001756-199601310-00033     Document Type: Article

References (25)

1. Carp JS and Anderson RJ, Brain Res 242, 247-254 (1982).
2. Maitra KK, Seth P, Mohanakumar KP et al. Brain Res Bull 28, 133-136 (1992).
3. Maitra KK, Seth P, Ross H-G et al. Brain Res Bull 28, 817-819 (1992).
4. Maitra KK, Seth P, Thewissen M et al. Acta Physiol Scand 148, 101-107 (1993).
5. Seth P, Gajendiran M, Meitra KK et al. Neurosci Lett 188, 217-220 (1993).
6. Kondo M, Fujiwara H and Tanaka C. Jap J Pharmacol 41, 39-46 (1988).
7. Dietz V, Feuerstein TJ and Berger W. Neurosci Lett 117, 81-86 (1990).
8. Shirouzu M, Anraku T, Iwashita Y at al. Experientia 46, 201-204 (1990).
9. Ridet J-L, Sandillon F, Rajaofetra N et al. Brain Res 988, 233-241 (1992).
10. Kamijo N, Nagao T and Ono H. Neuropharmacol 32, 777-783 (1993).
11. Laduron PM, Janssen PFP and Leyson JE. Biochem Pharmacol 27, 317-321 (1978).
12. Lum JT and Piercey MF. Eur J Pharmacol 149, 9-15 (1988).
13. Walters JR and Roth RH. Naunyn-Schmiedeberg's Arch Pharmacol 296, 5-14 (1976).
14. DiChiara G, Porceddu ML, Vargiu L et al. Nature 264, 564-567 (1976).
15. Gessa GL, Porceddu ML, Collu M et al. Eur J Pharmacol 109, 269-274 (1985).
16. Vaccheri A, Dall'Olio R, Gandolfi O et al. Psychopharmacology 89, 265-268 (1986).
17. Napier TC, Givens BS, Schulz DW et al. J Pharmacol Exp Ther 236, 838-845 (1986).
18. Demenge P, Feuerstein C, Mouchet P et al. Eur J Pharmacol 66, 117-120 (1980).
19. Dubois A, Savasta M, Curet O et al. Neuroscience 19, 125-137 (1986).
20. Broman J and Ådahl F. NeuroReport 5, 1801-1804 (1994).
21. Mitchell PR and Doggett NS. Life Sci 26, 2073-2081 (1980).
22. Braun AR and Chase TN. Eur J Pharmacol 131, 301-306 (1986).
23. Kropf W and Kuschinsky K. Neuropharmacology 32, 493-500 (1993).
24. Robertson GS and Robertson HA. Trends Pharmacol Sci 8, 295-299 (1987).
25. Schlosser W, Horst WD, Spiegel HE et al. Neuropharmacology 11, 417-426 (1972).